UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Thanks to advances in the treatment of HIV ... were living with HIV and taking antiretroviral therapy, while the other half did not have HIV. The researchers found that 22 percent of people ...

Absolute and relative disparities in HIV diagnosis rates were observed between Black and White individuals in the United States from 2017 to 2021, suggesting the need to actively mitigate social ...

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...

Proof-of-Concept Study to Find Functional Cure for HIV July 24, 2024 — Researchers conducted a breakthrough proof-of-concept study that found an HIV-like virus particle that could cease the need ...

Janssen’s single-tablet regimen Symtuza has been approved last year by the European Commission for the treatment of HIV in the EU. Sanofi is also working on an antibody HIV treatment that can ...